COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product

This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing…